AMNI.ST实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 21:25):

Stats
今日成交量	1.79M
平均成交量	23.82M
市值	10.30M
EPS	SEK-0.00938 ( 2023-11-27 )
下一个收益日期	( SEK0 ) 2024-05-21
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-0.0300
ATR14	SEK0 (0.00%)

Amniotics AB (publ) 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Amniotics AB (publ) 财务报表

Annual	2023
营收:	SEK0
毛利润:	SEK-2.30M (0.00 %)
EPS:	SEK-0.0676

FY	2023
营收:	SEK0
毛利润:	SEK-2.30M (0.00 %)
EPS:	SEK-0.0676

FY	2022
营收:	SEK0
毛利润:	SEK-1.79M (0.00 %)
EPS:	SEK-0.300

FY	2021
营收:	SEK0.00
毛利润:	SEK0.00 (0.00 %)
EPS:	SEK-3.34

Financial Reports:

No articles found.

Amniotics AB (publ)

Amniotics AB (publ) develops, manufactures, and sells stem cell therapies based on mesenchymal stem cells to treat severe life-threatening diseases. The company's lead drug candidate is PulmoStem for the treatment of inflammatory and fibrotic lung disease. It also develops CogniStem for the treatment of CNS indications; NephroStem for the treatment of kidney-specific indications; and CutiStem for the treatment of dermatological indications. The company offers contract development and contract manufacturing services for advanced therapy medicinal products to the pharmaceutical industries, universities, and hospitals. Amniotics AB (publ) was incorporated in 2015 and is based in Lund, Sweden.